SU-E-T-104: Commissioning and Dosimetric Characteristics of TrueBeam System: Composite Data of Three TrueBeam Machines

INTRODUCTION

A TrueBeam linear accelerator (TB-LINAC) is designed to deliver standard flattened and flattening-filter-free (FFF) beams. In our institute, three TB-LINAC units are installed. In this work, composite data of the three units and multi-unit comparison are presented.

METHODS

Each TB-LINAC can deliver photon beams from 4MV to 15MV, electron beams from 6MeV to 22MeV, and 6MV-FFF and 10MV-FFF. Dosimetric characteristics are systematically measured for commissioning including percent depth dose (PDD), beam profile, relative scatter factor, dynamic leaf shift, output factor and MLC leakage. Critic considerations of Pion of FFF photon beams and dosimetric penumbra are investigated.

RESULTS

All measured PDDs and profiles of photon and electron matched well across the three machines. Beam data were quantitatively compared and combined through average to yield composite beam data. The discrepancies among the machines were quantified using standard deviation (SD). For example, the mean SD of the PDDs among the three units is 0.12%, and the mean SD of the profiles is 0.40% for 10MV-FFF open fields. The variations of Pion of the chamber CC13 is 1.2±0.1% under 6MV-FFF and 2.0±0.5% from dmax to the 18cm-off-axis point at 35cm depth under 40×40cm² . The measured relative output factors range from 0.866 to 1.141 with the mean discrepancy of 0.06±0.04% among the three units. The measured wedge factors range from 0.863 to 1.254 with the mean overall discrepancy of 0.04±0.04%. The mean MLC transmission and dynamic leaf shift were measured from 1.0% to 1.5% and from 0.77mm to 0.96 mm from 4MV to 15MV. The mean penumbra of various photon beams are measured from 5.88±0.09mm to 5.99±0.13mm from 4MV to 15MV at 10cm depth of 10×10 cm² .

CONCLUSIONS

Dosimetric data demonstrated that the three units could and had been matched well. The systematically measured data might be useful for future reference.

Improving the quantitative accuracy of optical-emission computed tomography by incorporating an attenuation correction: application to HIF1 imaging

Optical computed tomography (optical-CT) and optical-emission computed tomography (optical-ECT) are new techniques for imaging the 3D structure and function (including gene expression) of whole unsectioned tissue samples. This work presents a method of improving the quantitative accuracy of optical-ECT by correcting for the 'self'-attenuation of photons emitted within the sample. The correction is analogous to a method commonly applied in single-photon-emission computed tomography reconstruction. The performance of the correction method was investigated by application to a transparent cylindrical gelatin phantom, containing a known distribution of attenuation (a central ink-doped gelatine core) and a known distribution of fluorescing fibres. Attenuation corrected and uncorrected optical-ECT images were reconstructed on the phantom to enable an evaluation of the effectiveness of the correction. Significant attenuation artefacts were observed in the uncorrected images where the central fibre appeared approximately 24% less intense due to greater attenuation from the surrounding ink-doped gelatin. This artefact was almost completely removed in the attenuation-corrected image, where the central fibre was within approximately 4% of the others. The successful phantom test enabled application of attenuation correction to optical-ECT images of an unsectioned human breast xenograft tumour grown subcutaneously on the hind leg of a nude mouse. This tumour cell line had been genetically labelled (pre-implantation) with fluorescent reporter genes such that all viable tumour cells expressed constitutive red fluorescent protein and hypoxia-inducible factor 1 transcription-produced green fluorescent protein. In addition to the fluorescent reporter labelling of gene expression, the tumour microvasculature was labelled by a light-absorbing vasculature contrast agent delivered in vivo by tail-vein injection. Optical-CT transmission images yielded high-resolution 3D images of the absorbing contrast agent, and revealed highly inhomogeneous vasculature perfusion within the tumour. Optical-ECT emission images yielded high-resolution 3D images of the fluorescent protein distribution in the tumour. Attenuation-uncorrected optical-ECT images showed clear loss of signal in regions of high attenuation, including regions of high perfusion, where attenuation is increased by increased vascular ink stain. Application of attenuation correction showed significant changes in an apparent expression of fluorescent proteins, confirming the importance of the attenuation correction. In conclusion, this work presents the first development and application of an attenuation correction for optical-ECT imaging. The results suggest that successful attenuation correction for optical-ECT is feasible and is essential for quantitatively accurate optical-ECT imaging.